Poseida Therapeutics' Series C Round

Poseida Therapeutics raised a round of funding on April 22, 2019.

Poseida Therapeutics is a clinical-stage biotechnology company translating gene engineering technologies into lifesaving treatments for patients with high unmet medical need. The company is developing…

Articles about Poseida Therapeutics' Series C Round: